Skip to main content

Clinical Guideline for Treating Acute Respiratory Insufficiency with Invasive Ventilation and Extracorporeal Membrane Oxygenation: Updated Evidence- Based Recommendations for Choosing Modes and Setting Parameters of Mechanical Ventilation.

Respiration; international review of thoracic diseases2025-12-11PubMed
Total: 78.5Innovation: 7Impact: 9Rigor: 8Citation: 8

Summary

This 2025 GRADE-based guideline refines invasive ventilation for acute respiratory failure, shifting from early neuromuscular blockade toward early assisted strategies in moderate-to-severe ARDS, and introducing cautious, case-by-case recommendations for adaptive modes (e.g., ASV/INTELLiVENT-ASV, NAVA). It reinforces lung-protective ventilation (VT ~6 mL/kg PBW, plateau ≤30 cmH2O, driving pressure ≤14 cmH2O), individualized higher PEEP in moderate/severe ARDS, oxygen targets (SaO2/SpO2 92–96% or PaO2 70–90 mmHg), and continuous monitoring with capnography.

Key Findings

  • Early neuromuscular blockade is no longer favored in moderate-to-severe ARDS; early assisted strategies are suggested when feasible.
  • Adaptive ventilation modes (ASV/INTELLiVENT-ASV) and NAVA may be considered case-by-case; PAV/PAV+ is not recommended.
  • Lung-protective ventilation targets: VT ≈6 mL/kg PBW (4–8 range), plateau pressure ≤30 cmH2O, driving pressure ≤14 cmH2O.
  • PEEP should be higher in moderate/severe ARDS and individualized using bedside physiology.
  • Oxygen targets (SaO2/SpO2 92–96% or PaO2 70–90 mmHg) and continuous monitoring including capnography are endorsed.

Clinical Implications

Adopt early assisted ventilation when appropriate in moderate-to-severe ARDS, maintain lung-protective settings with individualized PEEP, target SaO2/SpO2 92–96% (or PaO2 70–90 mmHg), and consider adaptive modes selectively while avoiding PAV/PAV+.

Why It Matters

Provides actionable, evidence-based ventilation targets and mode selection guidance likely to influence ICU practice and research priorities in ARDS care.

Limitations

  • Heterogeneity and low/very low certainty for several recommendations, especially adaptive modes
  • Guideline context tailored to DACH region; generalizability may vary

Future Directions

Prospective trials comparing early assisted vs. controlled strategies, rigorous evaluation of adaptive modes, and tools to individualize PEEP and oxygen targets.

Study Information

Study Type
Systematic Review
Research Domain
Treatment
Evidence Level
I - Guideline-derived synthesis using a systematic GRADE process of existing clinical evidence.
Study Design
OTHER